ARCHIVES

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

This article is from The Cancer Letter archive.

Vol. 38 No. 38 | October 12, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach

February 7, 2014